tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Clearmind says DSMB approves continuation of Phase I/IIa trial of CMND-100
PremiumThe FlyClearmind says DSMB approves continuation of Phase I/IIa trial of CMND-100
15d ago
Psychedelic: Clearmind reports results from first cohort in AUD trial
Premium
The Fly
Psychedelic: Clearmind reports results from first cohort in AUD trial
18d ago
SciSparc, Clearmind Medicine file Israeli patent application for depression
Premium
The Fly
SciSparc, Clearmind Medicine file Israeli patent application for depression
19d ago
Clearmind Medicine receives final approval to expand Phase 1/2a AUD trial
PremiumThe FlyClearmind Medicine receives final approval to expand Phase 1/2a AUD trial
26d ago
Clearmind announces notice of publication of patent for MEAI in China
Premium
The Fly
Clearmind announces notice of publication of patent for MEAI in China
27d ago
Clearmind Medicine completes first cohort treatment in Phase I/IIa AUD trial
Premium
The Fly
Clearmind Medicine completes first cohort treatment in Phase I/IIa AUD trial
29d ago
Clearmind Medicine completes first cohort treatment in Phase I/IIa AUD trial
PremiumThe FlyClearmind Medicine completes first cohort treatment in Phase I/IIa AUD trial
1M ago
Clearmind appoints Mary-Elizabeth Gifford as chief of global impact
Premium
The Fly
Clearmind appoints Mary-Elizabeth Gifford as chief of global impact
1M ago
Psychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial
Premium
The Fly
Psychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100